Breast Cancer News and Research

Latest Breast Cancer News and Research

Research reveals why Black women experience higher breast cancer mortality

New research from Sanford Burnham Prebys has revealed significant molecular differences between the breast cells of white and Black women that help explain why Black women experience higher breast cancer mortality.

9 Feb 2022

30-year-old cancer drug could get another shot, study says

A study by Virginia Commonwealth University Massey Cancer Center researchers published in today's print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer, which is the most aggressive form of breast cancer and has few targeted therapies.

9 Feb 2022

Study provides key information about the mechanism of breast cancer progression

Breast cancer is the most common cancer in women worldwide, yet despite medical advances, a cure for the tumors that spread locally and especially to distant sites remains out of reach.

7 Feb 2022

COVID-19 lockdown restrictions associated with increase in at-home drinking

Lockdown measures throughout 2020 have been linked to people in Scotland and England drinking more at home, according to new research.

4 Feb 2022

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

A new study by researchers at Yale Cancer Center shows using current standard human epidermal growth factor receptor 2 (HER2) assays as a diagnostic test may result in a mis-assignment of patients for treatment for breast cancer with a promising new drug.

3 Feb 2022

CECR2 gene inhibition prevents triple-negative breast cancer from metastasizing, study shows

A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing.

2 Feb 2022

Novel test uses cervical screening samples to detect breast and ovarian cancer

A new revolutionary test for detecting ovarian and breast cancer, which could potentially measure future cancer risk, is being developed by researchers from UCL's Institute for Women's Health.

2 Feb 2022

Experimental immunotherapy could help treat some people with metastatic breast cancer

An experimental form of immunotherapy that uses an individual's own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer, according to results from an ongoing clinical trial led by researchers at the National Cancer Institute's Center for Cancer Research, part of the National Institutes of Health.

1 Feb 2022

Neural stem cells plus HER2 inhibitor drug improve survival in mice with metastatic cancer

Neural stem cells (NSCs) engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2-positive breast cancer brain metastases, according to findings published in Proceedings of the National Academy of Sciences.

1 Feb 2022

Study reveals potential new way to treat breast cancer brain metastases

A study led by researchers at RCSI University of Medicine and Health Sciences and the Beaumont RCSI Cancer Centre (BRCC) has revealed a potential new way to treat secondary breast cancer that has spread to the brain, using existing drugs.

28 Jan 2022

Living human breast milk cells offer insight into breast cancer development

Researchers have explored the cellular changes that occur in human mammary tissue in lactating and non-lactating women, offering insight into the relationship between pregnancy, lactation, and breast cancer.

28 Jan 2022

Bisphenol A's effects are much worse than previously thought, experts say

The Endocrine Society joined a coalition of physicians, scientists and public health and environmental organizations to send a formal petition to the Food and Drug Administration (FDA), calling on the agency to rescind its approvals for bisphenol A (BPA) in adhesives and coatings and set strict limits on its use in plastics that contact food.

28 Jan 2022

Drug combo delivered in a nanoparticle formulation extends the survival of mice with medulloblastoma

UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma.

27 Jan 2022

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Death rates from ovarian cancer are predicted to fall by 17% in the UK and by 7% in EU countries in 2022 compared to 2017, according to new research published in the leading cancer journal Annals of Oncology today (Wednesday).

27 Jan 2022

Breast cancer drug shows promise in treating young infants with PIK3CA-related overgrowth spectrum

PIK3CA-related overgrowth spectrum (PROS) is a group of rare, incurable disorders caused by mutations in the PIK3CA gene that result in the malformation and overgrowth of various parts of the body.

26 Jan 2022

Peptide-enhanced antibody therapy may help treat breast cancer metastasis to bone

A moderate amount of a peptide-enhanced, biological cancer drug goes a long way in treating breast cancers that metastasize to the bone.

24 Jan 2022

Patients and providers have different expectations about access to medical records, study finds

While both patients and clinicians prioritize information transparency, a 21st Century Cures Act requirement for the immediate release of test and lab results is proving more controversial, according to recently published survey results of clinicians and patients.

24 Jan 2022

Prevalence and evolution of PTSD symptoms in cancer patients during COVID-19 pandemic

The focus of this study was to investigate the evolution of PTSD symptoms in cancer patients over the first year of the COVID19 pandemic.

21 Jan 2022

Cancer patients receiving treatment may mount inadequate immune response to COVID-19 vaccination

A study by researchers at Mayo Clinic Cancer Center has found that patients with cancer who receive chemotherapy - and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells - may mount an inadequate immune response to COVID-19 vaccination.

20 Jan 2022

Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

Eikonoklastes Therapeutics, a preclinical stage biopharmaceutical company, today announced it has completed a license with the University of California San Diego to add a novel gene therapy for the treatment of neurodegenerative diseases.

20 Jan 2022

Breast Cancer News and Research

Latest Breast Cancer News and Research

Research reveals why Black women experience higher breast cancer mortality

30-year-old cancer drug could get another shot, study says

Study provides key information about the mechanism of breast cancer progression

COVID-19 lockdown restrictions associated with increase in at-home drinking

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

CECR2 gene inhibition prevents triple-negative breast cancer from metastasizing, study shows

Novel test uses cervical screening samples to detect breast and ovarian cancer

Experimental immunotherapy could help treat some people with metastatic breast cancer

Neural stem cells plus HER2 inhibitor drug improve survival in mice with metastatic cancer

Study reveals potential new way to treat breast cancer brain metastases

Living human breast milk cells offer insight into breast cancer development

Bisphenol A's effects are much worse than previously thought, experts say

Drug combo delivered in a nanoparticle formulation extends the survival of mice with medulloblastoma

Death rates from ovarian cancer are predicted to fall by 2022 in EU countries

Breast cancer drug shows promise in treating young infants with PIK3CA-related overgrowth spectrum

Peptide-enhanced antibody therapy may help treat breast cancer metastasis to bone

Patients and providers have different expectations about access to medical records, study finds

Prevalence and evolution of PTSD symptoms in cancer patients during COVID-19 pandemic

Cancer patients receiving treatment may mount inadequate immune response to COVID-19 vaccination

Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in